•
Dec 31, 2016

Corcept Therapeutics Q4 2016 Earnings Report

Total Revenue
$23.8M
Previous year: $15M
+58.7%
EPS
$0.04
Previous year: $0.01
+300.0%
Gross Profit
$23.3M
Previous year: $14.6M
+59.2%
Cash and Equivalents
$51.5M
Previous year: $40.4M
+27.5%
Free Cash Flow
$18.3M
Total Assets
$68.8M
Previous year: $51.9M
+32.5%

Corcept Therapeutics

Corcept Therapeutics